Pastor C, Badia A, Sabrià J
Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Spain.
Neurosci Lett. 1996 Oct 4;216(3):187-90. doi: 10.1016/0304-3940(96)13029-9.
Nerve terminals obtained from rat brain cortex and hippocampus, were labelled with 0.04 microM of [3H]noradrenaline ([3H]NA). Thereafter the basal release of [3H]NA was measured in a Brandel superfusion apparatus, in the presence of alpha 1-adrenoceptor agonists (phenylephrine or noradrenaline) or these alpha 1-adrenoceptor agonists along with prazosin, an alpha 1-adrenoceptor antagonist. In cortical synaptosomes both alpha 1-adrenoceptor agonists increased the basal release of [3H]NA in a concentration-dependent manner (EC50 = 0.15 microM for phenylephrine and 12.6 microM for noradrenaline). Effects were reversed by 0.01 microM prazosin (EC50 = 2.46 and 130.1 microM, respectively). In synaptosomes from rat brain hippocampus, phenylephrine (EC50 = 1.28 microM) and noradrenaline (EC50 = 33.7 microM) also increased the [3H]NA release and prazosin (0.01 microM) shifted the corresponding concentration-response curves to the right (EC50 = 7.38 and 264.0 microM, respectively). Events produced by noradrenaline acting as alpha 1-adrenoceptor agonist did not show Ca2+ dependence. These results suggest (1) the presence of functional alpha 1-adrenoceptors in nerve terminals from rat brain cortex and hippocampus, (2) that these receptors seem to play a role in the presynaptic modulation of [3H]NA release, and (3) that intraterminal Ca2+ may be involved.
从大鼠大脑皮层和海马体获取的神经末梢,用0.04微摩尔的[³H]去甲肾上腺素([³H]NA)进行标记。此后,在Brandel超级灌注装置中测量[³H]NA的基础释放量,实验中存在α1 - 肾上腺素能受体激动剂(去氧肾上腺素或去甲肾上腺素),或者这些α1 - 肾上腺素能受体激动剂与α1 - 肾上腺素能受体拮抗剂哌唑嗪一起使用。在皮质突触体中,两种α1 - 肾上腺素能受体激动剂均以浓度依赖的方式增加[³H]NA的基础释放量(去氧肾上腺素的EC50 = 0.15微摩尔,去甲肾上腺素的EC50 = 12.6微摩尔)。0.01微摩尔的哌唑嗪可逆转这些效应(EC50分别为2.46和130.1微摩尔)。在大鼠脑海马体的突触体中,去氧肾上腺素(EC50 = 1.28微摩尔)和去甲肾上腺素(EC50 = 33.7微摩尔)也增加了[³H]NA的释放,而哌唑嗪(0.01微摩尔)使相应的浓度 - 反应曲线向右移动(EC50分别为7.38和264.0微摩尔)。去甲肾上腺素作为α1 - 肾上腺素能受体激动剂产生的效应不显示对Ca²⁺的依赖性。这些结果表明:(1)大鼠大脑皮层和海马体的神经末梢中存在功能性α1 - 肾上腺素能受体;(2)这些受体似乎在[³H]NA释放的突触前调节中发挥作用;(3)可能涉及末梢内的Ca²⁺。